Welker, Martin-Walter http://orcid.org/0000-0002-8687-9639
Weiler, Nina
Bechstein, Wolf Otto
Herrmann, Eva
Betz, Christoph
Schöffauer, Mark
Zeuzem, Stefan
Sarrazin, Christoph
Amann, Kerstin
Jung, Oliver
Article History
Received: 9 April 2018
Accepted: 13 June 2018
First Online: 26 June 2018
Compliance with ethical standards
:
: Martin-Walter Welker, Consultancies/speaker’s fees: AbbVie, Amgen, Bayer, BMS, Gilead, Novartis, Roche, Sequana Medical. Travel Support: AbbVie, Astellas, Bayer, BMS, Novartis, Janssen, Roche. Nina Weiler, Consultancies/speaker´s bureau for Astellas, Novartis. Wolf Otto Bechstein, Consultancies/speaker’s fees: Astellas, Celgene, Gilead, Integra, Medupdate, MerckSerono, Novartis, Teva. Eva Herrmann, nothing to report. Christoph Betz, noting to report. Mark Schöffauer, nothing to report. Stefan Zeuzem, Consultancies/speaker’s bureau for Abbvie, BMS, Gilead, Janssen, Merck. Christoph Sarrazin, Consultancies/Advisory boards: Abbott, BMS, Gilead, Janssen, Merck/MSD, Roche. Research support: Abbott, Gilead, Janssen, Siemens. Speaker: Abbott, BMS, Gilead, Janssen, Merck/MSD, Qiagen, Roche, Siemens. Kerstin Amann, Speaker/Advisory boards: Alexion, Böhringer Ingelheim. Oliver Jung, nothing to report. On behalf of the remaining authors, no financial, personal, or professional interests that could be construed to have influenced the paper have to be reported.
: Study approval was obtained by the local Ethics Committee for Medical Research in accordance with the 1975 Declaration of Helsinki.
: For this type of study formal consent is not required.